Literature DB >> 11379815

Cortical synapse loss in progressive supranuclear palsy.

E H Bigio1, M B Vono, S Satumtira, J Adamson, E Sontag, L S Hynan, C L White, M Baker, M Hutton.   

Abstract

Cortical synapse loss, the probable substrate of cognitive impairment in Alzheimer disease (AD), has not previously been evaluated in progressive supranuclear palsy (PSP). Hypothesizing that synapse loss would be greater in demented than non-demented PSP patients, we examined synaptophysin concentrations in 8 cases of PSP (5 demented and 3 nondemented cases). We found a decrease in mean synaptophysin concentration in these 8 cases in frontal, temporal, and parietal lobes, and in cerebellum, compared to the means in corresponding lobes of 16 controls. The decreases were similar to those in 28 cases of AD, but not as great. We determined synaptophysin concentration from motor cortex in only 4 of our PSP cases, 2 demented and 2 non-demented. The average concentrations in these 4 cases were lower than in AD motor cortex; both were lower than controls. When demented and non-demented PSP cases were compared, neocortical synaptophysin concentrations in non-demented PSP cases were lower than in demented cases. There appears to be a link between AD and PSP, in that synapse loss is found in both. However, the basis and significance of the prominent neocortical synapse loss in PSP, especially in non-demented subjects, remain to be explored.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11379815     DOI: 10.1093/jnen/60.5.403

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  19 in total

Review 1.  Is synaptic loss a unique hallmark of Alzheimer's disease?

Authors:  Stephen W Scheff; Janna H Neltner; Peter T Nelson
Journal:  Biochem Pharmacol       Date:  2014-01-09       Impact factor: 5.858

2.  Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability.

Authors:  Martijn C de Wilde; Cassia R Overk; John W Sijben; Eliezer Masliah
Journal:  Alzheimers Dement       Date:  2016-01-14       Impact factor: 21.566

3.  Yeast as a model system to study tau biology.

Authors:  Ann De Vos; Jayamani Anandhakumar; Jeff Van den Brande; Mathias Verduyckt; Vanessa Franssens; Joris Winderickx; Erwin Swinnen
Journal:  Int J Alzheimers Dis       Date:  2011-04-06

4.  Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice.

Authors:  Cristian A Lasagna-Reeves; Diana L Castillo-Carranza; Urmi Sengupta; Audra L Clos; George R Jackson; Rakez Kayed
Journal:  Mol Neurodegener       Date:  2011-06-06       Impact factor: 14.195

5.  Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration.

Authors:  Ming Tong; Lisa Longato; Suzanne M de la Monte
Journal:  BMC Endocr Disord       Date:  2010-03-19       Impact factor: 2.763

6.  Piericidin A aggravates Tau pathology in P301S transgenic mice.

Authors:  Matthias Höllerhage; Roman Deck; Anderson De Andrade; Gesine Respondek; Hong Xu; Thomas W Rösler; Mohamed Salama; Thomas Carlsson; Elizabeth S Yamada; Seham A Gad El Hak; Michel Goedert; Wolfgang H Oertel; Günter U Höglinger
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

7.  Role of Corpus Callosum Volumetry in Differentiating the Subtypes of Progressive Supranuclear Palsy and Early Parkinson's Disease.

Authors:  Abhishek Lenka; Shaik Afsar Pasha; Sandhya Mangalore; Lija George; Ketan Ramakant Jhunjhunwala; Bhawani Shankar Bagepally; Rajini M Naduthota; Jitender Saini; Ravi Yadav; Pramod Kumar Pal
Journal:  Mov Disord Clin Pract       Date:  2017-02-22

8.  In vivo coupling of dendritic complexity with presynaptic density in primary tauopathies.

Authors:  Elijah Mak; Negin Holland; P Simon Jones; George Savulich; Audrey Low; Maura Malpetti; Sanne S Kaalund; Luca Passamonti; Timothy Rittman; Rafael Romero-Garcia; Roido Manavaki; Guy B Williams; Young T Hong; Tim D Fryer; Franklin I Aigbirhio; John T O'Brien; James B Rowe
Journal:  Neurobiol Aging       Date:  2021-01-30       Impact factor: 4.673

9.  The role of tau in neurodegeneration.

Authors:  Tania F Gendron; Leonard Petrucelli
Journal:  Mol Neurodegener       Date:  2009-03-11       Impact factor: 14.195

10.  Synaptic Loss in Primary Tauopathies Revealed by [11 C]UCB-J Positron Emission Tomography.

Authors:  Negin Holland; P Simon Jones; George Savulich; Julie K Wiggins; Young T Hong; Tim D Fryer; Roido Manavaki; Selena Milicevic Sephton; Istvan Boros; Maura Malpetti; Frank H Hezemans; Franklin I Aigbirhio; Jonathan P Coles; John O'Brien; James B Rowe
Journal:  Mov Disord       Date:  2020-07-11       Impact factor: 9.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.